Literature DB >> 12244033

Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998.

Kenrad E Nelson1, Noya Galai, Mahboobeh Safaeian, Steffanie A Strathdee, David D Celentano, David Vlahov.   

Abstract

Although the incidence of and mortality from acquired immunodeficiency syndrome have declined recently in the United States, data are needed on the incidence of human immunodeficiency virus (HIV) and risk behaviors among injection drug users (IDUs). The authors studied the temporal trends of HIV incidence and risk behavior, ascertained through semiannual confidential interviews, between 1988 and 1998 in a cohort of 1,532 HIV-seronegative IDUs in Baltimore, Maryland. An additional 338 HIV-negative drug users were recruited in 1994 and were studied by using the same methods. Overall, 277 persons seroconverted to HIV during 8,826.45 person-years of follow-up, an incidence of 3.14 per 100 person-years. The incidence per 100 person-years declined over time from 4.45 in 1988-1990 to 3.35 in 1991-1994 to 1.84 in 1995-1998, a decline of 12% per year. HIV infections were associated with injection of cocaine, more frequent injection, needle sharing, and injection in a shooting galley. Sexual behavior variables associated with HIV incidence included a sexually transmitted infection, male homosexual behavior, and sex with another IDU. These data suggest that high-risk behavior and HIV incidence among IDUs have decreased recently in Baltimore. Nevertheless, additional prevention strategies are needed in these populations.

Entities:  

Mesh:

Year:  2002        PMID: 12244033     DOI: 10.1093/aje/kwf086

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  56 in total

1.  Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts.

Authors:  Robert Heimer; Lauretta E Grau; Erin Curtin; Kaveh Khoshnood; Merrill Singer
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

2.  From corrections to communities as an HIV priority.

Authors:  David Vlahov; Sara Putnam
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

3.  Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.

Authors:  Vana Sypsa; Mina Psichogiou; Dimitrios Paraskevis; Georgios Nikolopoulos; Chrissa Tsiara; Dimitra Paraskeva; Katerina Micha; Meni Malliori; Anastasia Pharris; Lucas Wiessing; Martin Donoghoe; Samuel Friedman; Don Des Jarlais; Georgios Daikos; Angelos Hatzakis
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

4.  Changes in blood-borne infection risk among injection drug users.

Authors:  Shruti H Mehta; Jacqueline Astemborski; Gregory D Kirk; Steffanie A Strathdee; Kenrad E Nelson; David Vlahov; David L Thomas
Journal:  J Infect Dis       Date:  2011-01-31       Impact factor: 5.226

5.  A prospective study of alcohol consumption and HIV acquisition among injection drug users.

Authors:  Chanelle J Howe; Stephen R Cole; David G Ostrow; Shruti H Mehta; Gregory D Kirk
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

Review 6.  Maintenance of endemicity in urban environments: a hypothesis linking risk, network structure and geography.

Authors:  R Rothenberg
Journal:  Sex Transm Infect       Date:  2007-02       Impact factor: 3.519

7.  The relationship of sexual dyad and personal network characteristics and individual attributes to unprotected sex among young injecting drug users.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  AIDS Behav       Date:  2007-08-10

Review 8.  Sensitivity analysis using elicited expert information for inference with coarsened data: illustration of censored discrete event times in the AIDS Link to Intravenous Experience (ALIVE) Study.

Authors:  Michelle Shardell; Daniel O Scharfstein; David Vlahov; Noya Galai
Journal:  Am J Epidemiol       Date:  2008-10-24       Impact factor: 4.897

9.  Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.

Authors:  April M Young; Jennifer R Havens
Journal:  Addiction       Date:  2011-10-26       Impact factor: 6.526

10.  Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women.

Authors:  Darcy F Phelan; Stephen J Gange; Linda Ahdieh-Grant; Shruti H Mehta; Gregory D Kirk; Keerti Shah; Patti Gravitt
Journal:  Sex Transm Dis       Date:  2009-03       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.